Annual Accounts Receivable
N/A
December 1, 2024
Summary
- JNJ annual accounts receivable is not available.
Performance
JNJ Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
December 1, 2024
Summary
- JNJ quarterly accounts receivable is not available.
Performance
JNJ Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
JNJ Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
JNJ Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Johnson & Johnson Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.17 B(+2.4%) |
| Jun 2024 | - | $15.79 B(+5.7%) |
| Mar 2024 | - | $14.95 B(+0.5%) |
| Dec 2023 | $14.87 B(+5.9%) | $14.87 B(+0.5%) |
| Sep 2023 | - | $14.80 B(-11.8%) |
| Jun 2023 | - | $16.78 B(+2.6%) |
| Mar 2023 | - | $16.35 B(+16.5%) |
| Dec 2022 | $14.04 B(-8.1%) | $14.04 B(-11.6%) |
| Sep 2022 | - | $15.89 B(-1.5%) |
| Jun 2022 | - | $16.14 B(+3.5%) |
| Mar 2022 | - | $15.59 B(+2.0%) |
| Dec 2021 | $15.28 B(+12.6%) | $15.28 B(+2.5%) |
| Sep 2021 | - | $14.91 B(+0.3%) |
| Jun 2021 | - | $14.87 B(-0.4%) |
| Mar 2021 | - | $14.94 B(+10.0%) |
| Dec 2020 | $13.58 B(-6.2%) | - |
| Dec 2020 | - | $13.58 B(-6.9%) |
| Sep 2020 | - | $14.58 B(-0.5%) |
| Jun 2020 | - | $14.64 B(-1.5%) |
| Mar 2020 | - | $14.87 B(+2.7%) |
| Dec 2019 | $14.48 B(+2.7%) | $14.48 B(-2.2%) |
| Sep 2019 | - | $14.80 B(+1.0%) |
| Jun 2019 | - | $14.65 B(+3.8%) |
| Mar 2019 | - | $14.12 B(+0.1%) |
| Dec 2018 | $14.10 B(+4.5%) | $14.10 B(+0.4%) |
| Sep 2018 | - | $14.05 B(-0.4%) |
| Jun 2018 | - | $14.11 B(-0.4%) |
| Mar 2018 | - | $14.17 B(+5.0%) |
| Dec 2017 | $13.49 B(+15.3%) | $13.49 B(+2.5%) |
| Sep 2017 | - | $13.15 B(-1.0%) |
| Jun 2017 | - | $13.28 B(+8.0%) |
| Mar 2017 | - | $12.30 B(+5.1%) |
| Dec 2016 | $11.70 B(+9.0%) | $11.70 B(-0.8%) |
| Sep 2016 | - | $11.80 B(-2.2%) |
| Jun 2016 | - | $12.06 B(+5.8%) |
| Mar 2016 | - | $11.41 B(+6.3%) |
| Dec 2015 | $10.73 B(-2.3%) | $10.73 B(-5.6%) |
| Sep 2015 | - | $11.37 B(-5.0%) |
| Jun 2015 | - | $11.97 B(+3.8%) |
| Mar 2015 | - | $11.53 B(+5.0%) |
| Dec 2014 | $10.98 B(-6.2%) | $10.98 B(-5.4%) |
| Sep 2014 | - | $11.62 B(-5.2%) |
| Jun 2014 | - | $12.26 B(+1.2%) |
| Mar 2014 | - | $12.12 B(+3.4%) |
| Dec 2013 | $11.71 B(+3.6%) | $11.71 B(-2.6%) |
| Sep 2013 | - | $12.03 B(+3.6%) |
| Jun 2013 | - | $11.61 B(+0.9%) |
| Mar 2013 | - | $11.52 B(+1.8%) |
| Dec 2012 | $11.31 B(+6.9%) | $11.31 B(+1.2%) |
| Sep 2012 | - | $11.18 B(+1.7%) |
| Jun 2012 | - | $10.99 B(+0.1%) |
| Mar 2012 | - | $10.98 B(+3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $10.58 B(+8.3%) | $10.58 B(+0.3%) |
| Sep 2011 | - | $10.55 B(-3.9%) |
| Jun 2011 | - | $10.98 B(+1.1%) |
| Mar 2011 | - | $10.86 B(+11.1%) |
| Dec 2010 | $9.77 B(+1.3%) | $9.77 B(-5.0%) |
| Sep 2010 | - | $10.29 B(+6.9%) |
| Jun 2010 | - | $9.63 B(-3.9%) |
| Mar 2010 | - | $10.02 B(+3.9%) |
| Dec 2009 | $9.65 B(-0.8%) | $9.65 B(-6.2%) |
| Sep 2009 | - | $10.28 B(+1.4%) |
| Jun 2009 | - | $10.13 B(+3.1%) |
| Mar 2009 | - | $9.83 B(+1.2%) |
| Dec 2008 | $9.72 B(+2.9%) | $9.72 B(-4.3%) |
| Sep 2008 | - | $10.16 B(-3.6%) |
| Jun 2008 | - | $10.54 B(+1.5%) |
| Mar 2008 | - | $10.38 B(+10.0%) |
| Dec 2007 | $9.44 B(+8.4%) | $9.44 B(+0.6%) |
| Sep 2007 | - | $9.38 B(-0.9%) |
| Jun 2007 | - | $9.47 B(+1.9%) |
| Mar 2007 | - | $9.29 B(+6.7%) |
| Dec 2006 | $8.71 B(+24.3%) | $8.71 B(+9.2%) |
| Sep 2006 | - | $7.98 B(-2.3%) |
| Jun 2006 | - | $8.16 B(+6.4%) |
| Mar 2006 | - | $7.67 B(+9.4%) |
| Dec 2005 | $7.01 B(+2.6%) | $7.01 B(-2.0%) |
| Sep 2005 | - | $7.15 B(-3.0%) |
| Jun 2005 | - | $7.38 B(+0.6%) |
| Mar 2005 | - | $7.34 B(+7.4%) |
| Dec 2004 | $6.83 B(+3.9%) | $6.83 B(-1.6%) |
| Sep 2004 | - | $6.94 B(-2.8%) |
| Jun 2004 | - | $7.14 B(+5.5%) |
| Mar 2004 | - | $6.77 B(+3.0%) |
| Dec 2003 | $6.57 B(+21.8%) | $6.57 B(+2.7%) |
| Sep 2003 | - | $6.40 B(-0.4%) |
| Jun 2003 | - | $6.43 B(+10.1%) |
| Mar 2003 | - | $5.84 B(+8.1%) |
| Dec 2002 | $5.40 B(+16.6%) | $5.40 B(+0.1%) |
| Sep 2002 | - | $5.39 B(-0.2%) |
| Jun 2002 | - | $5.41 B(+14.1%) |
| Mar 2002 | - | $4.74 B(+2.4%) |
| Dec 2001 | $4.63 B(+0.6%) | $4.63 B(-6.7%) |
| Sep 2001 | - | $4.96 B(+3.2%) |
| Jun 2001 | - | $4.80 B(+4.3%) |
| Mar 2001 | - | $4.61 B(+0.1%) |
| Dec 2000 | $4.60 B(+8.7%) | $4.60 B(+9.2%) |
| Sep 2000 | - | $4.21 B(-5.2%) |
| Jun 2000 | - | $4.44 B(+4.9%) |
| Dec 1999 | $4.23 B(+12.8%) | $4.23 B(+1.1%) |
| Sep 1999 | - | $4.19 B(+0.3%) |
| Jun 1999 | - | $4.17 B(+6.0%) |
| Mar 1999 | - | $3.94 B(+4.9%) |
| Dec 1998 | $3.75 B | $3.75 B |
FAQ
- What is the all time high annual accounts receivable for Johnson & Johnson?
- What is the all time high quarterly accounts receivable for Johnson & Johnson?
What is the all time high annual accounts receivable for Johnson & Johnson?
Johnson & Johnson all-time high annual accounts receivable is $15.28 B
What is the all time high quarterly accounts receivable for Johnson & Johnson?
Johnson & Johnson all-time high quarterly accounts receivable is $16.78 B